DOSE-RESPONSE ENDOCRINE PROFILES FOR A NOVEL RECOMBINANT FSH PREPARATION (FE 999049) DERIVED FROM A HUMAN CELL-LINE

被引：1
|
作者：
Andersen, A. Nyboe [1 ]
Barri, P.
Garcia-Velasco, J. A.
De Sutter, P.
Bosch, E.
Arce, J. -C. [2 ]
机构：
[1] Fertil Clin, Copenhagen, Denmark
[2] Global Clin R&D, Copenhagen, Denmark
来源：
FERTILITY AND STERILITY | 2013年 / 100卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2013.07.179
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-57
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [1] The influence of patient-specific variables and dose-response modelling in controlled ovarian stimulation with FE 999049, a human recombinant FSH derived from a human cell-line
    Roshammar, D.
    Klein, B. M.
    Arce, J. C.
    HUMAN REPRODUCTION, 2014, 29 : 323 - 323
  • [2] A randomised, assessor-blind, dose-response trial in patients undergoing COS for IVF/ICSI with a novel recombinant FSH (FE 999049) derived from a human cell line
    Andersen, A. Nyboe
    Fernandez-Sanchez, M.
    Bosch, E.
    Visnova, H.
    Barri, P.
    Garcia-Velasco, J. A.
    De Sutter, P.
    Fauser, B. J. C. M.
    Arce, J. C.
    HUMAN REPRODUCTION, 2013, 28 : 351 - 352
  • [3] A RANDOMIZED, ASSESSOR-BLIND, DOSE-RESPONSE TRIAL IN PATIENTS UNDERGOING CONTROLLED OVARIAN STIMULATION FOR IVF/ICSI WITH A NOVEL RECOMBINANT FSH PREPARATION (FE 999049) DERIVED FROM A HUMAN CELL-LINE.
    Arce, J. -C.
    Andersen, A. Nyboe
    Fernandez-Sanchez, M.
    Bosch, E.
    Visnova, H.
    Fauser, B. J. C. M.
    FERTILITY AND STERILITY, 2013, 100 (03) : S59 - S59
  • [4] The contribution of FSH receptor polymorphism on ovarian response and treatment efficiency following stimulation with FE 999049, a recombinant FSH from a human cell-line
    Arce, J. C.
    HUMAN REPRODUCTION, 2015, 30 : 438 - 438
  • [5] Relation between dose of FE 999049, a recombinant FSH derived from a human cell-line, used for controlled ovarian stimulation and number of oocytes, embryos and blastocysts
    Arce, J. C.
    Nyboe Andersen, A.
    Fernandez-Sanchez, M.
    Visnova, H.
    Bosch, E.
    Garcia-Velasco, J. A.
    Barri, P.
    de Sutter, P.
    Klein, B. M.
    Fauser, B. C. J. M.
    HUMAN REPRODUCTION, 2014, 29 : 322 - 323
  • [6] Different pharmacokinetic properties between a novel recombinant FSH (FE 999049) derived from a human cell line and follitropin alfa
    Sandstrom, R.
    Olsson, H.
    Grundemar, L.
    HUMAN REPRODUCTION, 2013, 28 : 352 - 352
  • [7] Impact of body weight of IVF/ICSI patients on the pharmacokinetics and pharmacodynamic responses to FE 999049, a recombinant FSH derived from a human cell-line
    Klein, B. M.
    Arce, J. C.
    HUMAN REPRODUCTION, 2014, 29 : 323 - 323
  • [8] A randomised, double-blind, active-controlled, multiple-dose trial investigating the pharmacokinetics and pharmacodynamics of a novel recombinant FSH (FE 999049) derived from a human cell line
    Olsson, H.
    Sandstrom, R.
    Grundemar, L.
    HUMAN REPRODUCTION, 2013, 28 : 351 - 351
  • [9] Follicular and endocrine dose responses according to anti-Mullerian hormone levels in IVF patients treated with a novel human recombinant FSH (FE 999049)
    Bosch, Ernesto
    Andersen, Anders Nyboe
    Barri, Pedro
    Garcia-Velasco, Juan Antonio
    de Sutter, Petra
    Fernandez-Sanchez, Manuel
    Visnova, Hana
    Klein, Bjarke M.
    Mannaerts, Bernadette
    Arce, Joan-Carles
    CLINICAL ENDOCRINOLOGY, 2015, 83 (06) : 902 - 912
  • [10] Dose-Exposure Proportionality of a Novel Recombinant Follicle-Stimulating Hormone (rFSH), FE 999049, Derived from a Human Cell Line, with Comparison Between Caucasian and Japanese Women After Subcutaneous Administration
    Olsson, Hakan
    Sandstrom, Rikard
    Bagger, Yu
    CLINICAL DRUG INVESTIGATION, 2015, 35 (04) : 247 - 253
12345